- The Effects of Cilazapril on Left Ventricular Remodeling after Coronary Intervention in Patients with Ischemic Heart Failure
-
Park HW, Jeong MH, Lee SH, Kang KT, Kim JW, Kim SH, Cho JH, Ahn YK, Cho JG, Park JC, Kang YJ, Kang JC
- KMID: 1858310
- Korean Circ J.
- 1998 Dec;28(12):1964-1972.
- doi: 10.4070/kcj.1998.28.12.1964
BACKGROUND AND OBJECTIVES: Angiotensin converting enzyme inhibitor (ACEI) is known to be effective in the prevention of left ventricular failure (LVF) after acute myocardial infarction. The aim of this study... -
- CITED
-
- Close
- SHARE
-
- Close
- A clinical study on the anti-Hypertensive effect of cilazapril in patients with mild to moderate essential hypertension
-
Kim HH, Kim KS, Lim HK, Lee BH, Lee CK
- KMID: 2229202
- Korean Circ J.
- 1993 Feb;23(1):129-135.
- doi: 10.4070/kcj.1993.23.1.129
BACKGROUND: In order to investigate the efficacy and safety of cilazapril, a recently developed angiotensin converting enzyme inhibitor, a clinical study was performed in the patients with mild to moderate... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Renin-angiotensin System Blockade on Tubulointerstitial Lesions in Adriamycin-induced Nephropathy
-
Lee DK, Han SW, Paik SS, Park MH, Lee JU, Kim HJ
- KMID: 2079422
- Korean J Nephrol.
- 2005 Jan;24(1):26-31.
PURPOSE: Effects of renin-angiotensin system blockade on tubulointerstitial lesions were examined in adriamycin-induced nephropathy. METHODS: Male Sprague-Dawley rats were used. The three experimental groups were intravenously injected with adriamycin (2... -
- CITED
-
- Close
- SHARE
-
- Close
- Upregulation of Renal Renin-Angiotensin System in Rats with Adriamycin-Induced Nephrosis
-
Kim SW, Lee JU, Han SW, Ryu JH, Oh YW, Kim NH, Choi KC, Kim HJ
- KMID: 1615005
- Korean J Physiol Pharmacol.
- 2002 Apr;6(2):127-130.
The present study was aimed to investigate whether the adriamycin-induced nephrosis is associated with an altered regulation of local renin-angiotensin system (RAS) in the kidney. Rats were subjected to a... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical Study on the Anti-Hypertensive Effect of Cilazapril in Mild to Moderate Hypertensive Patients
-
Han DS, Choi JH, Choi WC, Ha SK, Lee HY, Lee WK
- KMID: 2229167
- Korean Circ J.
- 1991 Aug;21(4):764-773.
- doi: 10.4070/kcj.1991.21.4.764
In order to investigate the efficacy and safety of oral cilazapril, a new angiotensin converting enzyme inhibitor, on essential hypertension, a single daily dose of 2.5 to 5.0mg cilazapril was... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in Laminin beta 1 Chain Expression in Renal Cortex by the Intervention with Cilazapril and Losartan on Adriamycin-Induced Nephropathy
-
Kim TJ, Chung HS, Paik DJ, Youn JH, Kim WK
- KMID: 1559380
- Korean J Anat.
- 2002 Oct;35(5):419-429.
Laminin, an extracellular matrix glycoprotein, is distributed in the basement membrane of renal glomerulus. Laminin has been demonstrated to regulate the development and differentiation of glomeruli and play an important... -
- CITED
-
- Close
- SHARE
-
- Close
- The effects of antiproliferative drugs at stenotic area associated with primary atherosclerotic lesions in apoE knockout mouse - Change of vascular remodeling
-
Seo HS, Lee EM, Ahn JC, Kim SM, Hwang IH, Hwang KS, Song WH, Lim DS, Park CG, Kim YH, Shim WJ, Oh DJ, Ro YM
- KMID: 2227380
- Korean Circ J.
- 2000 Apr;30(4):517-527.
- doi: 10.4070/kcj.2000.30.4.517
Apolipoprotein (apo) E deficient mouse can produce reproducible fixed stenotic primary atherosclerotic lesion, which reveals failure to remodel of vascular lumen, in the ascending aorta, external carotid, common carotid, iliac,... -
- CITED
-
- Close
- SHARE
-
- Close
- Randomized, Open Label, Multicenter Clinical Trial about the Effect of Cilazapril on Vascular Endothelial Function in Patients with Type 2 Diabetes Combined with Hypertension
-
Rhee SY, Woo JT, Baik SH, Lee HW, Lee IK, Kim HS, Lee MK, Shong MH, Cho CG, Park BH, Cha BS, Kim YS
- KMID: 2331794
- J Korean Diabetes Assoc.
- 2006 Nov;30(6):450-458.
BACKGROUND: The angiotensin converting enzyme inhibitor (ACEi) improves the vascular endothelial cell function and has a better clinical outcome by decreasing the LDL cholesterol oxidation, hypercoagulability, oxidative stress and improving... -
- CITED
-
- Close
- SHARE
-
- Close
